Northeast Investment Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$472K Hold
4,564
0.02% 147
2026
Q1
$328K Hold
4,564
0.01% 163
2025
Q4
$362K Sell
4,564
-84
-2% -$6.62K 0.01% 154
2025
Q3
$350K Buy
4,648
+424
+10% +$29.1K 0.01% 144
2025
Q2
$291K Sell
4,224
-110
-3% -$7.21K 0.01% 159
2025
Q1
$294K Sell
4,334
-3,455
-44% -$207K 0.01% 156
2024
Q4
$350K Sell
7,789
-13,162
-63% -$738K 0.02% 153
2024
Q3
$1.32M Sell
20,951
-17,442
-45% -$1.02M 0.06% 100
2024
Q2
$2.27M Sell
38,393
-141,025
-79% -$8.82M 0.11% 79
2024
Q1
$14.3M Sell
179,418
-27,842
-13% -$2.13M 0.7% 42
2023
Q4
$16.4M Sell
207,260
-16,168
-7% -$1.15M 0.88% 37
2023
Q3
$15.6M Sell
223,428
-32,948
-13% -$2.33M 0.92% 37
2023
Q2
$17.7M Sell
256,376
-8,499
-3% -$605K 1% 33
2023
Q1
$19.7M Buy
264,875
+3,644
+1% +$306K 1.19% 29
2022
Q4
$24.3M Sell
261,231
-3,483
-1% -$336K 1.55% 23
2022
Q3
$25.2M Buy
264,714
+4,476
+2% +$443K 1.71% 18
2022
Q2
$24.1M Sell
260,238
-4,452
-2% -$435K 1.54% 21
2022
Q1
$26.8M Buy
264,690
+1,195
+0.5% +$126K 1.41% 22
2021
Q4
$27.2M Buy
263,495
+8,655
+3% +$800K 1.33% 28
2021
Q3
$21.6M Buy
254,840
+13,668
+6% +$1.14M 1.16% 29
2021
Q2
$20.1M Buy
241,172
+3,437
+1% +$281K 1.08% 29
2021
Q1
$17.9M Buy
237,735
+4,617
+2% +$336K 1.06% 31
2020
Q4
$15.9M Buy
233,118
+7,326
+3% +$477K 0.97% 35
2020
Q3
$13.2M Buy
225,792
+1,395
+0.6% +$86.8K 0.88% 35
2020
Q2
$14.6M Buy
224,397
+11,335
+5% +$714K 1.09% 29
2020
Q1
$12.6M Buy
213,062
+888
+0.4% +$59.3K 1.16% 30
2019
Q4
$15.8M Buy
212,174
+3,848
+2% +$270K 1.16% 28
2019
Q3
$13.1M Sell
208,326
-35,344
-15% -$2.09M 1.05% 32
2019
Q2
$13.3M Sell
243,670
-32,400
-12% -$1.74M 1.05% 34
2019
Q1
$14.9M Buy
276,070
+2,848
+1% +$176K 1.25% 27
2018
Q4
$17.9M Buy
273,222
+909
+0.3% +$67.9K 1.72% 20
2018
Q3
$21.4M Buy
272,313
+985
+0.4% +$70.4K 1.71% 20
2018
Q2
$17.5M Sell
271,328
-241
-0.1% -$15.9K 1.48% 25
2018
Q1
$16.9M Sell
271,569
-15,862
-6% -$1.14M 1.49% 23
2017
Q4
$20.8M Sell
287,431
-5,028
-2% -$366K 1.75% 17
2017
Q3
$23.8M Sell
292,459
-3,687
-1% -$292K 2.11% 12
2017
Q2
$23.8M Sell
296,146
-2,717
-0.9% -$215K 2.17% 12
2017
Q1
$23.5M Sell
298,863
-4,097
-1% -$327K 2.2% 13
2016
Q4
$23.9M Buy
302,960
+8,408
+3% +$680K 2.29% 11
2016
Q3
$26.2M Buy
294,552
+1,127
+0.4% +$106K 2.62% 7
2016
Q2
$28.1M Sell
293,425
-5,226
-2% -$521K 2.83% 5
2016
Q1
$31M Sell
298,651
-5,068
-2% -$493K 3.18% 4
2015
Q4
$29.7M Sell
303,719
-571
-0.2% -$55.9K 3.08% 4
2015
Q3
$29.4M Sell
304,290
-4,012
-1% -$422K 3.17% 4
2015
Q2
$32.3M Sell
308,302
-5,134
-2% -$525K 3.27% 3
2015
Q1
$32.4M Sell
313,436
-8,573
-3% -$867K 3.17% 3
2014
Q4
$31M Sell
322,009
-1,411
-0.4% -$124K 3.03% 4
2014
Q3
$25.7M Buy
323,420
+643
+0.2% +$50.7K 2.59% 7
2014
Q2
$24.3M Sell
322,777
-2,841
-0.9% -$215K 2.44% 10
2014
Q1
$24.4M Sell
325,618
-8,791
-3% -$621K 2.59% 7
2013
Q4
$23.9M Sell
334,409
-198
-0.1% -$12.7K 2.68% 8
2013
Q3
$19M Sell
334,607
-1,959
-0.6% -$117K 2.3% 11
2013
Q2
$19.2M Buy
+336,566
New +$19.5M 2.47% 8

Other funds holding CVS

Northeast Investment Management's CVS Position: Q2 2026 in Review

Northeast Investment Management held its CVS Health (CVS) position steady in Q2 2026 at 4,564 shares worth $472K. The position accounts for 0.02% of the portfolio, ranked #147.

Northeast Investment Management first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $32.4M in Q1 2015. 937 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Northeast Investment Management held 4,564 shares of CVS Health worth $472K as of Q2 2026.
  • Northeast Investment Management left its CVS Health share count unchanged in Q2 2026.
  • CVS Health made up 0.02% of Northeast Investment Management's portfolio in Q2 2026, its #147 holding.
  • Northeast Investment Management first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
  • Northeast Investment Management's CVS Health position peaked at $32.4M in Q1 2015.
  • 937 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Northeast Investment Management's 13F filing for Q2 2026, filed 16 Jul 2026.